Women's Fem Dophilus

Formula re: Contains

GR-1/RC-14 and Vaginal Flora (also called microbiota)

General Statements: All Other Content

In one of the randomized clinical trials, 75% of women in the GR-1/RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement. Martinez, et al. Can J Microbiol 2009;55:133-138 Box contains smaller, Activ-Vial moisture-controlled desiccant bottle for better stability of probiotic bacteria. 25+ years of GR-1/RC-14 Research/Clinical studies 1988 First research on GR-1/RC-14 strains begin 27 Clinical studies published between 2001 and 2014 2006 Fem-Dophilus introduced (2006)

Suggested/Recommended/Usage/Directions

Usage: For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional. If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.

Precautions re: Pregnant or Nursing or Prescription Medications

Note: Consult a healthcare professional before using this product if you are trying to conceive, pregnant, or lactating, under the age of 18, or have a medical condition; if adverse reactions occur, discontinue use.

Precautions re: Children

Note: Consult a healthcare professional before using this product if you are trying to conceive, pregnant, or lactating, under the age of 18, or have a medical condition; if adverse reactions occur, discontinue use.

Formula re: Contains

Fem-Dophilus contains two patented and clinically documented probiotic strains, Lacticaseibacillus rhamnosus GR-1 and Limosilactobacillus reuteri RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote healthy vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.

Formulation re: Other

Updates based on official taxonomy reclassification.

Precautions re: Children

Keep out of the reach of children.

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Brand IP Statement(s) re: (c), (TM), (SM)

Under license from Chr. Hansen A/S and protected by Chr. Hansen A/S patents of the WO 00/35465 patent family, and others. RC-14 and GR-1 are registered trademarks of Chr. Hansen A/S. Strains Matter Jarrow Formulas probiotics contain clinically documented strains

Formulation re: Other

Vaginal/urinary tract health

Storage

No refrigeration necessary

General Statements: All Other Content

25+ years of research/clinical studies

Formulation re: Does NOT Contain

Free of major allergens

Formulation re: Vegetarian/Vegan

Suitable for vegetarians/vegans

FDA Statement of Identity

Oral Probiotic Supplement

Storage

Fem-Dophilus does not require refrigeration and best to store in cool, dry place. Avoid storage at temperature above 77 degrees F (25 degrees C). Refrigeration, however extends shelf life.

Formulation re: Does NOT Contain

No wheat, gluten, soybeans, dairy, egg, fish/shellfish, or peanuts/tree nuts.

Formulation re: Other

Minimum 5 billion viable cells at time of consumption, under recommended storage conditions and within Best Used Before date.

Formulation re: Does NOT Contain

Gluten free

Formulation re: Vegetarian/Vegan

V Vegan

Seals/Symbols

Ipro

Formulation re: Other

Made in Denmark by Chr. Hansen A/S

Brand IP Statement(s) re: (c), (TM), (SM)

Copyright 2021 Jarrow Formulas

Formulation re: Other

Veggie Cap